PATENT CLAIM ANALYSIS

Application Number: 16106546
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "235100"]

Abstract:
Attenuated vaccines to protect vertebrate animals and people against tick-born rickettsial,  Ehrlichia  and  Anaplasma  species infections is disclosed. Also disclosed are methods to modify the organism to achieve the desired immunity through the modification of a novel genetic region involved in pathogenesis. These compounds represent a needed vaccine against an organism causing life-threatening febrile illness in humans and animals, and also represent the potential to develop new classes of drugs targeting the gene products of genes Ech_0660, Ech_0379, and Ech_0230, and their homologs of other related rickettsial pathogens.

Claim (Index 18):
The method of  claim 1 , wherein said mutation comprises insertion of SEQ ID NO:8 or SEQ ID NO:9 into the target gene.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.43284
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15362137', '14072029', '14818221', '12677343', '15981950']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7545786038489408
- 35 USC 102 Novelty (BERT): 0.5188721476853883
- Combined Prediction Score: 0.7310079582325856
- Mean Citation Score: 271.548306
- Max Citation Score: 287.90863
- Similarity Product: 177.09444203025043

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test